Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…

Osteopore plunges from 1000% price surge to suspension order

Osteopore goes from a 1000% price surge on Wednesday to a suspension order today after failing…

Argenica Therapeutics dose test raises hopes for stroke victims

Biotech firm Argenica Therapeutics has initiated dosing for the first stroke patient in its Phase 2…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Avecho Biotechnology kicks off clinical trial for insomnia cure

Avecho Biotechnology (ASX: AVE) has embarked on a journey to treat insomnia, a prevalent sleep disorder,…

Race Oncology’s latest chemotherapy drug ‘RC220’ gets go-ahead

Race Oncology (ASX: RAC) has made further progress in the development of its proprietary bisantrene formulation…

Argenica shares jump on key designation from US FDA for infant brain injury drug

Argenica Therapeutics announced on Monday the company has won rare pediatric disease designation (RPDD) for its…

LTR Pharma gets a rise out of world’s first erectile dysfunction spray

LTR Pharma makes progress with its erectile dysfunction spray; SPONTAN® which is hoped to revolutionise the…